Assessment of male CVID patients for mutations in the Btk gene: how many have been misdiagnosed?

Citation
Sa. Weston et al., Assessment of male CVID patients for mutations in the Btk gene: how many have been misdiagnosed?, CLIN EXP IM, 124(3), 2001, pp. 465-469
Citations number
20
Categorie Soggetti
Immunology
Journal title
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
ISSN journal
00099104 → ACNP
Volume
124
Issue
3
Year of publication
2001
Pages
465 - 469
Database
ISI
SICI code
0009-9104(200106)124:3<465:AOMCPF>2.0.ZU;2-T
Abstract
The presentation of hypogammaglobulinaemia in young males without a family history of immunodeficiency can pose a diagnostic problem. In the past, the presence of B-cells has suggested a diagnosis of common variable immunodef iciency (CVID), although genotypic analysis has now clarified that individu als with B cells may have mutations in their Btk gene. In order to address the issue of how many male individuals with a clinical diagnosis of CVID do in fact have mutations in the Btk gene, we analysed a group of 24 male pat ients. Single-strand conformation polymorphism (SSCP) analysis was used to screen the patient cohort for mutations in the Btk gene. Given the size of the Btk gene, the number of patients in the cohort and the amount of availa ble DNA, multiplex PCR reactions were utilized to span the 19 exons and pro moter region of the gene. Where abnormal migration patterns were observed w ith multiplex PCR reactions, in nine of the 24 patients, the individual Btk gene fragments were re-amplified and analysed again by SSCP. Following thi s analysis, four patients continued to demonstrate abnormal SSCP migration patterns. However, direct sequencing of the relevant Btk gene fragments for these four CVID patients revealed a mutation in only one patient. The muta tion was the previously described polymorphism at position 2031 of Btk gene within exon 18. These results indicate that caution should be taken with t he application of SSCP analysis to mutation detection. While it has a role to play in screening large patient cohorts, direct sequencing is a necessar y adjunct to such analysis. Finally, the clinical diagnosis of CVID in this cohort successfully excluded males with Btk mutations.